A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research shows it's anything but ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
NFL player and college star at the University of Arizona had been battling prostate cancer and Parkinson's Disease prior to ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...